{"id":"W4410809877","doi":"10.1200/jco.2025.43.16_suppl.7529","title":"Daratumumab + bortezomib, lenalidomide, and dexamethasone (DVRd) vs VRd in transplant-ineligible (TIE)/transplant-deferred (TD) newly diagnosed multiple myeloma (NDMM): Phase 3 CEPHEUS trial cytogenetic subgroup analysis.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"Johnson and Johnson","keywords":"Medicine; Lenalidomide; Daratumumab; Bortezomib; Multiple myeloma; Dexamethasone; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001198929,0.0006801303,0.00164713,0.0003111695,0.0001840227,0.0006846631,0.0004748156,0.0005808873,0.002161189],"category_scores_gemma":[0.0009447168,0.0002301773,0.001866566,0.0003727839,0.0002981937,0.000420121,0.0002988025,0.001130838,0.0002393811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006839572,"about_ca_system_score_gemma":0.000712589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009656174,"about_ca_topic_score_gemma":0.004501488,"domain_scores_codex":[0.9996829,0.0001580911,0.0000312262,0.00005621725,0.00002230951,0.00004934857],"domain_scores_gemma":[0.9996156,0.000118479,0.0001104391,0.00003173732,0.00001433251,0.0001094799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.941158,0.002151337,0.007877847,0.0008053851,0.004956641,0.00009040932,0.00008021029,0.001175768,0.00370805,0.0001559992,0.001154626,0.03668573],"study_design_scores_gemma":[0.7681401,0.1809285,0.03133023,0.0001670476,0.01121573,0.0003261736,0.0001288675,0.002041891,0.001791837,0.0007463217,0.003139542,0.00004373642],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917502,0.005312616,0.0002286953,0.0002868727,0.0001149705,0.0006058537,0.0008619025,0.00002666653,0.0008122428],"genre_scores_gemma":[0.9959853,0.001463674,0.0003191112,0.0003213583,0.00009846754,0.0004326302,0.0006188315,0.000005742073,0.0007549534],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002161189,"threshold_uncertainty_score":0.007229865,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1031314274777195,"score_gpt":0.4679543763928254,"score_spread":0.364822948915106,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}